(Q35196321)

English

Advances in the development of biomarkers for Alzheimer's disease: from CSF total tau and Abeta(1-42) proteins to phosphorylated tau protein

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 August 2017

1 reference

Europe PubMed Central

Advances in the development of biomarkers for Alzheimer's disease: from CSF total tau and Abeta(1-42) proteins to phosphorylated tau protein (English)

1 reference

Europe PubMed Central

7 August 2017

0 references

Alzheimer's disease

0 references

phosphorylation

0 references

1

object named as

Harald Hampel

1 reference

Europe PubMed Central

7 August 2017

author name string

Alexander Goernitz

2

1 reference

Europe PubMed Central

7 August 2017

Katharina Buerger

3

1 reference

Europe PubMed Central

7 August 2017

publication date

1 August 2003

1 reference

Europe PubMed Central

7 August 2017

number of pages

11

1 reference

based on heuristic

inferred from page(s)

Brain Research Bulletin

1 reference

Europe PubMed Central

7 August 2017

61

1 reference

Europe PubMed Central

7 August 2017

243-253

1 reference

Europe PubMed Central

7 August 2017

3

1 reference

Europe PubMed Central

7 August 2017

Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease” 11The names of the Working Group Members and the names of the Working Group Advisory Committee Members are listed in the Appendix A(section VI)

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Tau protein in cerebrospinal fluid from semantic dementia patients

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cerebrospinal fluid tau and Abeta42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Apolipoprotein E genotyping and cerebrospinal fluid tau protein: implications for the clinical diagnosis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

CSF phosphorylated tau protein and mild cognitive impairment: a prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

No increase in cerebrospinal fluid tau protein levels in patients with vascular dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

CSF total tau, Abeta42 and phosphorylated tau protein as biomarkers for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Increasing cerebrospinal fluid tau levels in a subgroup of Alzheimer patients with apolipoprotein E allele epsilon 4 during 14 months follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cerebrospinal fluid tau protein shows a better discrimination in young old (<70 years) than in old old patients with Alzheimer's disease compared with controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Differentiation of geriatric major depression from Alzheimer's disease with CSF tau protein phosphorylated at threonine 231.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A4 amyloid protein deposition and the diagnosis of Alzheimer's disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinic-based cases with frontotemporal dementia show increased cerebrospinal fluid tau and high apolipoprotein E epsilon4 frequency, but no tau gene mutations.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Worldwide prevalence and incidence of dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Biological markers and the treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased tau in the cerebrospinal fluid of patients with frontotemporal dementia and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Discriminant power of combined cerebrospinal fluid tau protein and of the soluble interleukin-6 receptor complex in the diagnosis of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Levels of nonphosphorylated and phosphorylated tau in cerebrospinal fluid of Alzheimer's disease patients : an ultrasensitive bienzyme-substrate-recycle enzyme-linked immunosorbent assay

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of heterogeneous A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Phosphorylated tau in human cerebrospinal fluid is a diagnostic marker for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Large-scale, multicenter study of cerebrospinal fluid tau protein phosphorylated at serine 199 for the antemortem diagnosis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

AD neuropathology.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased cerebrospinal fluid tau in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cerebrospinal fluid A beta42 is increased early in sporadic Alzheimer's disease and declines with disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined assessment of tau and neuronal thread protein in Alzheimer's disease CSF

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Longitudinal study of cerebrospinal fluid levels of tau, A beta1-40, and A beta1-42(43) in Alzheimer's disease: a study in Japan.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Decreased CSF amyloid beta42 and normal tau levels in dementia with Lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Highly increased CSF tau protein and decreased beta-amyloid (1-42) in sporadic CJD: a discrimination from Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of tau phosphorylated at threonine 231 in cerebrospinal fluid of Alzheimer's disease patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnostic accuracy of Alzheimer's disease: a neuropathological study.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Tau protein is a potential biological marker for normal pressure hydrocephalus

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Tau protein in cerebrospinal fluid is significantly increased at the earliest clinical stage of Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence of dementia and Alzheimer's disease in elderly community residents of south-western France

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinico-neuropathological correlation of Alzheimer's disease in a community-based case series.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cerebrospinal fluid amyloid beta(1-42) levels in the mild cognitive impairment stage of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Tau Protein in Cerebrospinal Fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased CSF tau protein in corticobasal degeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Tau and apo E in CSF: potential aid for discriminating Alzheimer's disease from other dementias.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Tau in cerebrospinal fluids: establishment of the sandwich ELISA with antibody specific to the repeat sequence in tau.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cerebrospinal fluid tau protein levels in demented and nondemented alcoholics.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cerebrospinal fluid levels of amyloid beta-protein in Alzheimer's disease: inverse correlation with severity of dementia and effect of apolipoprotein E genotype.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cerebrospinal fluid levels of amyloid beta-peptide1-42, but not tau have positive correlation with brain glucose metabolism in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined Analysis of CSF Tau Levels and [(123)I]Iodoamphetamine SPECT in Mild Cognitive Impairment: Implications for a Novel Predictor of Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Decreased beta-amyloid1-42 in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt–Jakob disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

CSF phosphorylated tau is a possible marker for discriminating Alzheimer's disease from dementia with Lewy bodies. Phospho-Tau International Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Mild cognitive impairment: clinical characterization and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cerebrospinal protein tau is elevated in early Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cerebrospinal beta-amyloid ((1-42)) in early Alzheimer's disease: association with apolipoprotein E genotype and cognitive decline.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Total tau protein immunoreactivity in lumbar cerebrospinal fluid of patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

CSF beta-amyloid, cognition, and APOE genotype in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination assay of CSF tau, A beta 1-40 and A beta 1-42(43) as a biochemical marker of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Both total and phosphorylated tau are increased in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

CSF levels of tau, beta-amyloid(1-42) and GAP-43 in frontotemporal dementia, other types of dementia and normal aging

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A population-based study of tau protein and ubiquitin in cerebrospinal fluid in 85-year-olds: relation to severity of dementia and cerebral atrophy, but not to the apolipoprotein E4 allele.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Longitudinal stability of CSF tau levels in Alzheimer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Amyloid beta protein 42(43) in cerebrospinal fluid of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

CSF tau is related to apolipoprotein E genotype in early Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Three-year follow-up of cerebrospinal fluid tau, beta-amyloid 42 and 40 concentrations in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Tau protein concentrations in cerebrospinal fluid of patients with dementia of the Alzheimer type

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of tau protein in cerebrospinal fluid between corticobasal degeneration and progressive supranuclear palsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cerebrospinal fluid tau and beta-amyloid(1-42) in dementia disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Mitotic phosphoepitopes precede paired helical filaments in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantification of axonal damage in traumatic brain injury: affinity purification and characterization of cerebrospinal fluid tau proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2803%2900087-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0361-9230(03)00087-X

1 reference

Europe PubMed Central

7 August 2017

1 reference

Europe PubMed Central

7 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35196321&oldid=1966117273"